Login / Signup

Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis.

Robert M SchilkeCassidy M R BlackburnTemitayo T BamgboseMatthew D Woolard
Published in: Biomolecules (2020)
Phospholipases are a family of lipid-altering enzymes that can either reduce or increase bioactive lipid levels. Bioactive lipids elicit signaling responses, activate transcription factors, promote G-coupled-protein activity, and modulate membrane fluidity, which mediates cellular function. Phospholipases and the bioactive lipids they produce are important regulators of immune cell activity, dictating both pro-inflammatory and pro-resolving activity. During atherosclerosis, pro-inflammatory and pro-resolving activities govern atherosclerosis progression and regression, respectively. This review will look at the interface of phospholipase activity, immune cell function, and atherosclerosis.
Keyphrases
  • cardiovascular disease
  • transcription factor
  • type diabetes
  • small molecule
  • tissue engineering